SYT1 and Alzheimer disease: Because synaptic degeneration is a prominent feature in the brain in Alzheimer’s disease, we expected synaptotagmin-1 to be altered in these patients compared with controls and therefore it might serve as a valuable biomarker for Alzheimer’s disease.